Clarius Group LLC Sells 206 Shares of Cardinal Health, Inc. $CAH

Clarius Group LLC trimmed its position in Cardinal Health, Inc. (NYSE:CAH) by 8.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 2,271 shares of the company’s stock after selling 206 shares during the period. Clarius Group LLC’s holdings in Cardinal Health were worth $382,000 as of its most recent filing with the SEC.

Other large investors also recently modified their holdings of the company. Greykasell Wealth Strategies Inc. bought a new position in shares of Cardinal Health in the 1st quarter valued at $26,000. GW&K Investment Management LLC lifted its stake in shares of Cardinal Health by 113.4% in the 1st quarter. GW&K Investment Management LLC now owns 271 shares of the company’s stock valued at $37,000 after acquiring an additional 144 shares during the last quarter. NBC Securities Inc. bought a new position in shares of Cardinal Health in the 1st quarter valued at $48,000. Zions Bancorporation National Association UT bought a new position in shares of Cardinal Health in the 1st quarter valued at $52,000. Finally, Garde Capital Inc. bought a new position in shares of Cardinal Health in the 1st quarter valued at $52,000. 87.17% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In related news, CEO Stephen M. Mason sold 41,575 shares of the business’s stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $148.82, for a total value of $6,187,191.50. Following the completion of the sale, the chief executive officer directly owned 26,085 shares of the company’s stock, valued at $3,881,969.70. The trade was a 61.45% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Jason M. Hollar sold 35,901 shares of the business’s stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $150.04, for a total value of $5,386,586.04. Following the completion of the sale, the chief executive officer directly owned 200,000 shares of the company’s stock, valued at $30,008,000. The trade was a 15.22% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 271,676 shares of company stock worth $40,489,525 over the last three months. Insiders own 0.12% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently issued reports on CAH. Jefferies Financial Group set a $150.00 target price on Cardinal Health in a research report on Tuesday, August 12th. Citigroup reaffirmed a “neutral” rating and set a $170.00 target price (up from $157.00) on shares of Cardinal Health in a research report on Friday, June 13th. Wall Street Zen lowered Cardinal Health from a “strong-buy” rating to a “buy” rating in a research report on Saturday, August 2nd. Weiss Ratings reaffirmed a “buy (b)” rating on shares of Cardinal Health in a research report on Saturday, September 27th. Finally, Evercore ISI lowered their target price on Cardinal Health from $200.00 to $190.00 and set an “outperform” rating for the company in a research report on Wednesday, August 13th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $166.00.

Cardinal Health Trading Up 0.5%

CAH stock opened at $155.25 on Tuesday. The stock has a 50-day moving average price of $152.05 and a 200-day moving average price of $150.67. Cardinal Health, Inc. has a 1-year low of $106.98 and a 1-year high of $168.44. The firm has a market cap of $36.88 billion, a PE ratio of 24.07, a price-to-earnings-growth ratio of 1.31 and a beta of 0.71.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Tuesday, August 12th. The company reported $2.08 earnings per share for the quarter, topping the consensus estimate of $2.03 by $0.05. Cardinal Health had a negative return on equity of 74.45% and a net margin of 0.70%.The firm had revenue of $60.16 billion during the quarter, compared to analyst estimates of $60.91 billion. During the same period last year, the company posted $1.84 EPS. The business’s quarterly revenue was up .5% on a year-over-year basis. Cardinal Health has set its FY 2026 guidance at 9.300-9.500 EPS. On average, analysts forecast that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.

Cardinal Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Wednesday, October 1st will be given a $0.5107 dividend. The ex-dividend date of this dividend is Wednesday, October 1st. This represents a $2.04 annualized dividend and a dividend yield of 1.3%. Cardinal Health’s dividend payout ratio (DPR) is 31.63%.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.